Althea offers cGMP plasmid production, protein production, formulation and filling services. Plasmid DNA and protein production are offered using both Althea’s industry-leading manufacturing process as well as client developed processes. A range of options are available for formulation and filling services ranging from semi- automated to fully- automated processes for vials and syringes. Althea is focused on offering highly responsive customer service, flexible scheduling, and rapid turnaround times to meet the requirements of both early stage clinical programs and commercial programs alike.
Althea Technologies Names Karen Daniels as President of the Company's Bio-Services Division
SAN DIEGO – July 17, 2007 -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that Karen Daniels has joined the company as President of the Bio-Services Division. Ms. Daniels, a seasoned senior executive with experience in both public and private high-growth technology companies, represents the latest addition to Althea’s management team as the company continues its rapid expansion in both capacity and capabilities including commercial manufacturing operations.
“We are delighted that Karen Daniels has joined Althea,” stated Dr. Magda Marquet, Co-President and Co-CEO of Althea. “Her proficient management experience in positions such as President and COO in companies with annual revenues over $100M significantly complements and strengthens our management team. Her expertise in strategic planning, operations management, staff development and the complex logistics of facilities development will contribute greatly as we bring our new manufacturing facilities on-line.” The appointment of Ms. Daniels will also permit the company’s Chief Operations Officer, Rick Hancock to devote full attention to Althea’s new commercial businesses including the commissioning activities required for the cGMP manufacturing facilities under construction.
“I am pleased to join Althea with the opportunity to contribute my experience to the dynamic growth of the company and I look forward to building upon the foundation of quality and dedicated service for which the company is known. I am honored and excited to be working with Dr. Magda Marquet and Dr. François Ferré along with the excellent team that Althea has formed under their leadership,” added Ms. Daniels.
Ms. Daniels brings over 20 years of senior management experience to Althea having held executive positions at Genetronics, Plexus Corporation and multinational companies like TDK before her most recent post at Vidacare Corporation, a medical device company offering innovative vascular access solutions for emergency medicine.
About Althea Technologies, Inc.
Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing and development services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea’s services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, aseptic filling, and gene quantification using real-time PCR and gene expression analysis under GLP conditions. Additionally, Althea has introduced new services and technologies for the identification and development of genetic biomarkers with innovative programs such as the company’s proprietary Express Pathway℠. For more information, visit www.altheatech.com.Contact:
| Althea Technologies, Inc. Alan Moore Executive Vice President & Chief Business Officer (858) 882-0205 amoore@altheatech.com |
Althea Technologies
A leading provider of contract services to
the pharmaceutical and biotechnology industries
11040 Roselle Street | San Diego, CA 92121-1205
Toll-free 1-888-4ALTHEA
info@altheatech.com